Arbutus Biopharma Corporation
ABUS • NASDAQ • Stock Fundamentals
Arbutus Biopharma Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lindsay Androski, with a market cap of $859.3M.
Market Cap$859.3M
Employees73.0
CEOLindsay Androski
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Arbutus Biopharma Corporation FAQ
Common questions about Arbutus Biopharma Corporation
Arbutus Biopharma Corporation (ABUS) has a market capitalization of $859.3M and trades on NASDAQ.
Arbutus Biopharma Corporation has approximately 73 employees.